Funding search · EIN 273322123 · Scottsdale, AZ

Ben and Catherine Ivy Foundation

Name: Ben and Catherine Ivy Foundation grants, 2022–2025
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

153
grants reported: $61.6M
total given: 2022–2025
filing years: $250,000
median grant

Based on grants this organization reported to the IRS for tax years 2022–2025. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

payment award adult translational glioma glioblastoma tumor research

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

0 grants matching “infectious disease”

No grants to show here.

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

Neuro Trials Llc10 grants · $22.4M
Neurotrials Llc4 grants · $8.6M
St Joseph'S Foundation6 grants · $7.9M
Society of St Vincent De Paul3 grants · $1.6M
Johns Hopkins Hospital5 grants · $1.4M
City of Hope Medical Center4 grants · $1.2M
University of Tx Md Anderson Cancer5 grants · $1.1M
Vanguard Charitable2 grants · $950,000
University of Virginia3 grants · $900,000
Rector Visitors of Univ of Va3 grants · $900,000

Giving over time

$16.0M

2022

$14.8M

2023

$14.4M

2024

$16.5M

2025

Grant history

The 100 largest of 153 grants.

$6.0M
St Joseph'S Foundation · Phoenix, AZ · 2023
Ivy brain tumor center at barrow neurological institute capital expenditures.
$5.5M
Neurotrials Llc · Phoenix, AZ · 2022
Prepayment of 2023 cerebrospinal fluid analysis.
$5.0M
Neuro Trials Llc · Phoenix, AZ · 2022
Ivy brain tumor center building expansion special grant amendment.
$4.3M
Neuro Trials Llc · Phoenix, AZ · 2025
Special grant - funding for employment and special needs.
$3.8M
Neuro Trials Llc · Phoenix, AZ · 2023
Multiple awards:1) development of triple-drug cocktails to induce glioblastoma.2) ucsf preclinical core for drug development at the ivy brain tumor center.3)10 year ibtc grant4) matching funds national gbm day
$2.8M
Neuro Trials Llc · Phoenix, AZ · 2024
7th installment payment for theivy brain tumor center.
$2.8M
Neuro Trials Llc · Phoenix, AZ · 2025
8th installment payment for theivy brain tumor center.
$2.3M
Neurotrials Llc · Phoenix, AZ · 2025
Building expansion - payment #5
$1.6M
Neuro Trials Llc · Phoenix, AZ · 2025
Cerebrospinal fluid analysis.
$1.4M
Neuro Trials Llc · Phoenix, AZ · 2024
Cerebrospinal fluid analysis. (3rd payment)
$1.0M
Society of St Vincent De Paul · Phoenix, AZ · 2024
Center for purpose, hope and mission as part of the common ground.
$925,000
Vanguard Charitable · Warwick, RI · 2024
Making philanthropy as effective and efficient as possible, ensuring that charitable dollars are used wisely and that their impact is maximized.
$900,000
St Joseph'S Foundation · Phoenix, AZ · 2024
St. Joseph's lobby remodel.
$714,675
Phoenix Police Foundation · Phoenix, AZ · 2024
For specific needs.
$525,000
St Joseph'S Foundation · Phoenix, AZ · 2024
Lab chemistry analyzers, pathology lab slide stainer, hematology analyzer.
$520,000
Maricopa Community Colleges Foundat · Tempe, AZ · 2024
Nursing workforce development program.
$450,000
Neurotrials Llc · Phoenix, AZ · 2022
Cerebrospinal fluid analysis with t-gen.
$420,675
Neurotrials Llc · Phoenix, AZ · 2024
Ivy brain tumor center - phoenix sky harbor advertising for clinical trials.
$380,000
Society of St Vincent De Paul · Phoenix, AZ · 2023
Center for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encour… read allCenter for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encourage the whole family to participate. less
$368,660
St Joseph'S Foundation · Phoenix, AZ · 2025
supports patient care, medical education, research and community outreach at St. Joseph Hospital.
$300,500
Swedish Medical Center · Seattle, WA · 2023
Assess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping … read allAssess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping of cell types. less
$300,000
City of Hope Medical Center · Duarte, CA · 2025
Dr. Brown - translational adult glioma award. (2nd payment)
$300,000
Cleveland Clinic · Cleveland, OH · 2025
Dr. Yu - translational adult glioma award. (2nd payment)
$300,000
Johns Hopkins Hospital · Baltimore, MD · 2025
Dr. Zhou - translational adult glioma award. (1st payment)
$300,000
Massachusetts General · Boston, MA · 2025
Dr. Badr - translational adult glioma award. (2nd payment)
$300,000
Md Anderson Cancer Center · Houston, TX · 2025
Dr. Calin - translational adult glioma award. (2nd payment)
$300,000
Neuro Trials Llc · Phoenix, AZ · 2025
Dr. Mehta - translational adult giloma award (1st payment)
$300,000
Regents of the University of Califo · Oakland, CA · 2025
Dr. Butowski - translational adult glioma award (2nd payment).
$300,000
Regents of University of Michigan · Ann Arbor, MI · 2025
Dr. Wahl - translational adult giloma award (1st payment)
$300,000
Swedish Health Services · Seattle, WA · 2025
Dr. Puchalski - translational adult glioma award. (2nd payment)
$300,000
Translational Genomics Research Tge · Phoenix, AZ · 2025
Dr. Mike berens - translational adult giloma award (1st payment).
$300,000
Children'S Hospital of Philadelphia · Philadelphia, PA · 2024
Dr. Ma - translational adult glioma award. (2nd and last payment)
$300,000
City of Hope Medical Center · Duarte, CA · 2024
Dr. Brown - translational adult glioma award. (2nd and last payment)
$300,000
City of Hope Medical Center · Duarte, CA · 2024
Dr. Brown - translational adult glioma award. (1st payment)
$300,000
Cleveland Clinic · Cleveland, OH · 2024
Dr. Yu - translational adult glioma award. (1st payment)
$300,000
Massachusetts General · Boston, MA · 2024
Dr. Badr - translational adult glioma award. (1st payment)
$300,000
Md Anderson Cancer Center · Houston, TX · 2024
Dr. Calin - translational adult glioma award. (1st payment)
$300,000
Rector Visitors of Univ of Va · Charlottesville, VA · 2024
Dr. Sheybani - translational adult glioma award. (2nd and last payment)
$300,000
Rector Visitors of Univ of Va · Charlottesville, VA · 2024
Dr. Li - translational adult glioma award. (2nd and last payment)
$300,000
Rector Visitors of Univ of Va · Charlottesville, VA · 2024
Dr. Amounader - translational adult glioma award. (2nd and last payment)
$300,000
Regents of the University of Califo · Oakland, CA · 2024
Dr. Butowski - 2024 translational adult glioma award.
$300,000
Swedish Health Services · Seattle, WA · 2024
Dr. Puchalski - translational adult glioma award. (1st payment)
$300,000
Children'S Hospital of Philadelphia · Philadelphia, PA · 2023
Engineering a multi-antigen targeting car t therapy with confined activites within the tumor microenvironment to treat antigenically heterogenous adult glioblastoma.
$300,000
City of Hope Medical Center · Duarte, CA · 2023
Phase i clinical trial to evaluate the feasibility, safety, and clinical efficacy of tgf-resistant ilira2-car t cells for treatment of recurrent glioblastoma. Pmt #1 of 2.
$300,000
Mayo Clinic · Jacksonville, FL · 2023
Identify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to… read allIdentify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to effectively treat this disease. Payment 2 of 2. less
$300,000
Mayo Clinic College of Medicine · Rochester, MN · 2023
Evaluate candidate glioma csf proteomic signatures to help understand and monitor glioma evolution in living patients during standard of care and experimental immunotherapy. Payment 2 of 2.
$300,000
Memorial Sloan Kettering Cancer Cen · New York, NY · 2023
Discover and describe dormant tumor cells called cancer stem cells that reside within adult glioma and are resistant to current therapies. Payment 2 of 2.
$300,000
Uc San Diego · La Jolla, CA · 2023
Small molecule regulation of rest protein levels provides an ideal platform for developing a new therapeutic for the treatment of glioblastoma multiforme. Payment 2 of 2.
$300,000
University of Tx Md Anderson Cancer · Houston, TX · 2023
Project seeks to preclinically optimize novel therapeutic approaches for atrx-deficient malignant gliomas targeting g-quadruplex dna secondary structure. Payment 2 of 2.
$300,000
University of Virginia · Charlottesville, VA · 2023
Develop small molecule inhibitors of a newly identified oncogene in glioblastoma. Pmt 1 of 2.
$300,000
University of Virginia · Charlottesville, VA · 2023
Develop and deploy strategies for leveraging mri-guided focused ultrasound therapy to potentiate car-t cell therapy against adult high-grade gliomas. Pmt 1 of 2.
$300,000
University of Virginia · Charlottesville, VA · 2023
Develop and test new therapies for glioblastoma using micornas. Pmt 1 of 2.
$300,000
H Lee Moffitt Cancer Center · Rochester, MN · 2022
In examining the role of tumors cells in modulating bone marrow-derived macrophages and microglia, this study seeks to tailor novel therapeutics for targeting of tumor associated macrophages. Payment 2 of 2.
$300,000
Mayo Clinic College of Medicine · Rochester, MN · 2022
Evaluate candidate glioma csf proteomic signatures to help understand and monitor glioma evolution in living patients during standard of care and experimental immunotherapy. Payment 1 of 2.
$300,000
Memorial Sloan Kettering Cancer Cen · New York, NY · 2022
Discover and describe dormant tumor cells called cancer stem cells that reside within adult glioma and are resistant to current therapies. Payment 1 of 2.
$300,000
Swedish Medical Center · Seattle, WA · 2022
Assess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping … read allAssess combinations of small molecules and immunotherapies for killing glioblastoma tumor cells in a personalized ex vivo ecosystem with intact tumor microenvironment using multiplex immunochemistry and spatial mapping of cell types. Payment 1 of 2. less
$300,000
Uc San Diego · La Jolla, CA · 2022
Small molecule regulation of rest protein levels provides an ideal platform for developing a new therapeutic for the treatment of glioblastoma multiforme. Payment 1 of 2.
$300,000
Univ of Miami Miller School of Medi · Miami, FL · 2022
Using patient derived orthotopic xenograft models and a novel immunocompetent model of gbm, the efficacy of a mtl-mmp inhibitor in combination with radiation/tmz will be tested to determine its effects on the immune com… read allUsing patient derived orthotopic xenograft models and a novel immunocompetent model of gbm, the efficacy of a mtl-mmp inhibitor in combination with radiation/tmz will be tested to determine its effects on the immune component of the tumor microenvironment. Payment 2 of 2. less
$300,000
Univ of New Mexico Health Sciences · Albuquerque, NM · 2022
Identify mechanisms underlying inflammatory cell contribution to the emergence of the recurrent tumor by single-cell analysis of residual disease in glioblastoma patients. Payment 2 of 2.
$300,000
University of Michigan · Ann Arbor, MI · 2022
New methods will be developed to measure the activity of tumor metabolic pathways in patients with glioblastoma and to determine whether drugs designed to block these pathways are suitable. Payment 2 of 2.
$300,000
University of Tx Md Anderson Cancer · Houston, TX · 2022
Project seeks to preclinically optimize novel therapeutic approaches for atrx-deficient malignant gliomas targeting g-quadruplex dna secondary structure. Payment 1 of 2.
$300,000
Yale Cancer Center · New Haven, CT · 2022
Use of a novel transformational platform for rapid identification of targets and treatments to inhibit growth and invasion of glioblastoma cells based on rapid patient sample screening using novel nano-engineering techn… read allUse of a novel transformational platform for rapid identification of targets and treatments to inhibit growth and invasion of glioblastoma cells based on rapid patient sample screening using novel nano-engineering techniques. Payment 2 of 2. less
$298,592
Indiana University Foundation · Bloomington, IN · 2024
Dr. Hao - translational adult glioma award. (2nd and last payment)
$298,592
Indiana University Foundation · Bloomington, IN · 2023
Determine the structural basis and molecular mechanism of action of sum01 degraders in treatment of glioblastoma, alone and in combination with current standard chemo and radiotherapy.
$298,575
Johns Hopkins Hospital · Baltimore, MD · 2025
Dr. Raman - translational adult glioma award. (2nd payment)
$298,575
Johns Hopkins Hospital · Baltimore, MD · 2024
Dr. Raman - translational adult glioma award. (1st payment)
$268,998
Mayo Clinic · Jacksonville, FL · 2022
Identify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to… read allIdentify the oncogenic signaling dependencies that characterize each of the cellular subpopulations that comprise a glioblastoma tumor, and from this information construct a non-toxic combination of kinase inhibitors to effectively treat this disease. Payment 1 of 2. less
$250,000
Fred Hutchison Cancer Research Cent · Seattle, WA · 2025
Dr gujral - emerging leader award. (2nd payment)
$250,000
Johns Hopkins Hospital · Baltimore, MD · 2025
Dr schreck - emerging leader award. (2nd payment)
$250,000
Loyola University of Chicago · Chicago, IL · 2025
Dr. Wainwright - emerging leader award (1st payment).
$250,000
Neuro Trials Llc · Phoenix, AZ · 2025
Dr. Tovmasyan - emerging leader award (1st payment)
$250,000
Stanford University · Stanford, CA · 2025
Dr. Beinat - emerging leader award (1st payment).
$250,000
Stanford University · Stanford, CA · 2025
Dr. Solomon - emerging leader award (1st payment).
$250,000
Fred Hutchison Cancer Research Cent · Seattle, WA · 2024
Dr gujral - emerging leader award. (1st payment)
$250,000
Johns Hopkins Hospital · Baltimore, MD · 2024
Dr schreck - emerging leader award. (1st payment)
$250,000
Regents of University of Michigan · Ann Arbor, MI · 2024
Dr. Wahl - emerging leader award. (2nd and last payment)
$250,000
Columbia University Irving Medical · New York, NY · 2023
Targeting the glioblastoma master regulator cebp a pharmacokinetics and pharmacodynamics surgical study of st101. Payment 2 of 2.
$250,000
University of Michigan · Ann Arbor, MI · 2023
Develop quantitative methods to assess methionnine metabolism and test the efficacy of methionne-directed therapeutics in mouse models and patients with glioblastoma. Pmt 1 of 2.
$250,000
University of Tx Md Anderson Cancer · Houston, TX · 2023
Develop safe and potent drugs that can turn the tumor immune microenvironment from suppressive to permissive, thereby helping the immune system to recognize and kill glioblastoma. Payment 2 of 2.
$250,000
Columbia University Irving Medical · New York, NY · 2022
Targeting the glioblastoma master regulator cebp a pharmacokinetics and pharmacodynamics surgical study of st101. Payment 1 of 2.
$250,000
Society of St Vincent De Paul · Phoenix, AZ · 2022
Center for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encour… read allCenter for family wellness established to focus on the prevention and management of chronic diseases through nutrition, physical activity and overall wellness. Its culturally grounded bilingual education programs encourage the whole family to participate. Payment #3. less
$250,000
University of Tx Md Anderson Cancer · Houston, TX · 2022
Develop safe and potent drugs that can turn the tumor immune microenvironment from suppressive to permissive, thereby helping the immune system to recognize and kill glioblastoma. Payment 1 of 2.
$250,000
Vanderbilt University · Nashville, TN · 2022
Using single-cell and systems biology approaches in glioblastoma, cell subtypes will be mapped to glioblastoma tissues and experimental models, enabling identification and preclinical targeting of interactions between c… read allUsing single-cell and systems biology approaches in glioblastoma, cell subtypes will be mapped to glioblastoma tissues and experimental models, enabling identification and preclinical targeting of interactions between cancer cells, immune cells, and location specific resident brain cells. Payment 2 of 2. less
$250,000
Virginia Tech · Roanoke, VA · 2022
To inhibit tumor cell invasion and invasion, targeted therapeutics will be coupled to biomarker-based imaging in patient-specific models of glioblastoma. Payment 2 of 2.
$210,430
Ut Southwestern Medical Center · Dallas, TX · 2022
Preclinical investigation of focus ultrasound guided delivery to facilitate a lipoprotein-omega-3 fatty acid-based biological therapy in glioblastoma. Payment 2 of 2.
$208,347
Mayo Clinic College of Medicine · Rochester, MN · 2022
Immunostimulatory bacterial antigens expressed in oncolytic viral platforms will be tested in preclinical models of glioblastoma to overcome immune checkpoint inhibitor resistance. Payment 2 of 2.
$200,000
Damon Runyon Cancer Research Fdn · New York, NY · 2025
Dr. John prensner - clinical investigator's award.
$200,000
Damon Runyon Cancer Research Fdn · New York, NY · 2024
Dr. John prensner - clinical investigator's award.
$200,000
Neuro Trials Llc · Phoenix, AZ · 2022
Deposit for ivy brain tumor center building lobby.
$150,000
Swedish Medical Center · Seattle, WA · 2024
High-throughput screening (hts) clinical trial treating recurrent gbm patients.
$135,000
St Joseph'S Foundation · Phoenix, AZ · 2023
supports patient care, medical education, research and community outreach at St. Joseph Hospital.
$130,500
Maricopa Community Colleges Foundat · Tempe, AZ · 2023
The foundation actively seeks contributions from a variety of private sources including individuals, corporations, and foundations and believes that everyone has the opportunity to improve their lives through education.… read allThe foundation actively seeks contributions from a variety of private sources including individuals, corporations, and foundations and believes that everyone has the opportunity to improve their lives through education. MCCCDF works to fulfill this vision with its mission to boldly impact the community through innovative and strategic partnerships for the growth and benefit of the Maricopa Community Colleges, its students, faculty, and staff. less
$130,000
Damon Runyon Cancer Research Fdn · New York, NY · 2023
Investigation of a biomarker phase 2 study to evaluate targeted therapy harboring specific genetic alterations. 4th and final pmt.
$120,000
Damon Runyon Cancer Research Fdn · New York, NY · 2022
Investigation of a biomarker phase 2 study to evaluate targeted therapy harboring specific genetic alterations. Payment 3
$102,898
Translational Genomics Research Tge · Phoenix, AZ · 2025
The ivy neurological sciences internship program
$101,314
Translational Genomics Research Tge · Phoenix, AZ · 2024
2023 - 2024 internship program at tgen designed to give students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within th… read all2023 - 2024 internship program at tgen designed to give students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within the neurological sciences. less
$100,218
Translational Genomics Research Tge · Phoenix, AZ · 2023
Neurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research… read allNeurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within the neurological sciences. less
$100,000
Translational Genomics Research Tge · Phoenix, AZ · 2024
Mike berens - dipg pediatric glioma research.
$78,293
Translational Genomics Research Tge · Phoenix, AZ · 2022
Neurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research… read allNeurological sciences internship program at tgen designed to give high school and undergraduate students intensive, hands-on research experience working alongside a mentor-scientist to learn about translational research while investigating questions within neurological sciences. less
$25,000
Women'S Board of Barrow Neurologica · Phoenix, AZ · 2025
Ivy brain tumor center.

View all 153 grants →

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.